| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CFO
1 company
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $80.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,200 | $11.12 | $35,584.00 | - | -12.6% | +100.9% | |
| Sep 26, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,500 | $14.63 | $21,945.00 | - | -17.1% | -27.4% | |
| Aug 6, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $13.81 | $27,620.00 | - | -7.7% | -14.7% | |
| Aug 5, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 5,500 | $13.18 | $72,490.00 | - | -1.3% | -11.6% | |
| Jul 23, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,500 | $15.89 | $23,835.00 | - | -16.5% | -28.4% | |
| Jun 13, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 174,825 | $14.30 | $2,499,997.50 | +3.3% | -6.0% | -38.0% | |
| Apr 1, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,000 | $19.08 | $57,240.00 | - | -11.9% | -51.4% | |
| Mar 22, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,500 | $19.98 | $49,950.00 | - | -22.0% | -43.4% | |
| Mar 20, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,500 | $17.68 | $26,520.00 | - | -13.1% | -38.3% | |
| Mar 5, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 30,500 | $12.49 | $380,945.00 | +0.6% | +11.3% | -4.9% |